Depression as a risk factor for osteoporosis independent of sarcopenia in hemodialysis patients: findings from a multicenter cross-sectional study
Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental health issue in this population. Despite the prevalence of these conditions, the interrelationships among them remain poorly understood in HD pat...
Saved in:
Published in | BMC nephrology Vol. 26; no. 1; pp. 35 - 11 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
23.01.2025
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental health issue in this population. Despite the prevalence of these conditions, the interrelationships among them remain poorly understood in HD patients.
In this multicenter cross-sectional study, 858 HD patients from 7 dialysis centers were recruited. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry. Skeletal muscle mass index (SMI) was calculated from body composition data obtained through multifrequency bioimpedance analysis (BIA), while handgrip strength (HGS) was measured with a dynamometer. Gait speed was evaluated with a 4-meter walk test, and depression was assessed using the Patient Health Questionnaire-9 (PHQ-9).
Among the 858 participants (524 men, 334 women), 39.2% had osteoporosis. The prevalence of sarcopenia and depression was 18.9% and 42.1%, respectively. Logistic regression analysis showed that SMI was significantly associated with a decreased risk of osteoporosis (OR = 0.638, 95% CI = 0.494-0.823, P = 0.001), while HGS was not(OR = 0.990, 95% CI = 0.963-1.017, P = 0.449). HD patients with sarcopenia were 1.92 times more likely to have osteoporosis than those without sarcopenia. Most notably, after adjusting for both sarcopenia and SMI, the risk of osteoporosis in HD patients with depression was 1.45 times higher than in those without depression (OR = 1.452, 95% CI = 1.060-1.989, P = 0.020).
In HD patients, increased muscle mass, rather than muscle strength, is linked to a lower risk of osteoporosis. Notably, depression emerges as a significant risk factor for osteoporosis in this population, highlighting the need for mental health considerations in managing bone health. |
---|---|
AbstractList | Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental health issue in this population. Despite the prevalence of these conditions, the interrelationships among them remain poorly understood in HD patients.
In this multicenter cross-sectional study, 858 HD patients from 7 dialysis centers were recruited. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry. Skeletal muscle mass index (SMI) was calculated from body composition data obtained through multifrequency bioimpedance analysis (BIA), while handgrip strength (HGS) was measured with a dynamometer. Gait speed was evaluated with a 4-meter walk test, and depression was assessed using the Patient Health Questionnaire-9 (PHQ-9).
Among the 858 participants (524 men, 334 women), 39.2% had osteoporosis. The prevalence of sarcopenia and depression was 18.9% and 42.1%, respectively. Logistic regression analysis showed that SMI was significantly associated with a decreased risk of osteoporosis (OR = 0.638, 95% CI = 0.494-0.823, P = 0.001), while HGS was not(OR = 0.990, 95% CI = 0.963-1.017, P = 0.449). HD patients with sarcopenia were 1.92 times more likely to have osteoporosis than those without sarcopenia. Most notably, after adjusting for both sarcopenia and SMI, the risk of osteoporosis in HD patients with depression was 1.45 times higher than in those without depression (OR = 1.452, 95% CI = 1.060-1.989, P = 0.020).
In HD patients, increased muscle mass, rather than muscle strength, is linked to a lower risk of osteoporosis. Notably, depression emerges as a significant risk factor for osteoporosis in this population, highlighting the need for mental health considerations in managing bone health. Abstract Background Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental health issue in this population. Despite the prevalence of these conditions, the interrelationships among them remain poorly understood in HD patients. Methods In this multicenter cross-sectional study, 858 HD patients from 7 dialysis centers were recruited. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry. Skeletal muscle mass index (SMI) was calculated from body composition data obtained through multifrequency bioimpedance analysis (BIA), while handgrip strength (HGS) was measured with a dynamometer. Gait speed was evaluated with a 4-meter walk test, and depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). Results Among the 858 participants (524 men, 334 women), 39.2% had osteoporosis. The prevalence of sarcopenia and depression was 18.9% and 42.1%, respectively. Logistic regression analysis showed that SMI was significantly associated with a decreased risk of osteoporosis (OR = 0.638, 95% CI = 0.494–0.823, P = 0.001), while HGS was not(OR = 0.990, 95% CI = 0.963–1.017, P = 0.449). HD patients with sarcopenia were 1.92 times more likely to have osteoporosis than those without sarcopenia. Most notably, after adjusting for both sarcopenia and SMI, the risk of osteoporosis in HD patients with depression was 1.45 times higher than in those without depression (OR = 1.452, 95% CI = 1.060–1.989, P = 0.020). Conclusions In HD patients, increased muscle mass, rather than muscle strength, is linked to a lower risk of osteoporosis. Notably, depression emerges as a significant risk factor for osteoporosis in this population, highlighting the need for mental health considerations in managing bone health. BackgroundOsteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental health issue in this population. Despite the prevalence of these conditions, the interrelationships among them remain poorly understood in HD patients.MethodsIn this multicenter cross-sectional study, 858 HD patients from 7 dialysis centers were recruited. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry. Skeletal muscle mass index (SMI) was calculated from body composition data obtained through multifrequency bioimpedance analysis (BIA), while handgrip strength (HGS) was measured with a dynamometer. Gait speed was evaluated with a 4-meter walk test, and depression was assessed using the Patient Health Questionnaire-9 (PHQ-9).ResultsAmong the 858 participants (524 men, 334 women), 39.2% had osteoporosis. The prevalence of sarcopenia and depression was 18.9% and 42.1%, respectively. Logistic regression analysis showed that SMI was significantly associated with a decreased risk of osteoporosis (OR = 0.638, 95% CI = 0.494–0.823, P = 0.001), while HGS was not(OR = 0.990, 95% CI = 0.963–1.017, P = 0.449). HD patients with sarcopenia were 1.92 times more likely to have osteoporosis than those without sarcopenia. Most notably, after adjusting for both sarcopenia and SMI, the risk of osteoporosis in HD patients with depression was 1.45 times higher than in those without depression (OR = 1.452, 95% CI = 1.060–1.989, P = 0.020).ConclusionsIn HD patients, increased muscle mass, rather than muscle strength, is linked to a lower risk of osteoporosis. Notably, depression emerges as a significant risk factor for osteoporosis in this population, highlighting the need for mental health considerations in managing bone health. Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental health issue in this population. Despite the prevalence of these conditions, the interrelationships among them remain poorly understood in HD patients.BACKGROUNDOsteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental health issue in this population. Despite the prevalence of these conditions, the interrelationships among them remain poorly understood in HD patients.In this multicenter cross-sectional study, 858 HD patients from 7 dialysis centers were recruited. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry. Skeletal muscle mass index (SMI) was calculated from body composition data obtained through multifrequency bioimpedance analysis (BIA), while handgrip strength (HGS) was measured with a dynamometer. Gait speed was evaluated with a 4-meter walk test, and depression was assessed using the Patient Health Questionnaire-9 (PHQ-9).METHODSIn this multicenter cross-sectional study, 858 HD patients from 7 dialysis centers were recruited. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry. Skeletal muscle mass index (SMI) was calculated from body composition data obtained through multifrequency bioimpedance analysis (BIA), while handgrip strength (HGS) was measured with a dynamometer. Gait speed was evaluated with a 4-meter walk test, and depression was assessed using the Patient Health Questionnaire-9 (PHQ-9).Among the 858 participants (524 men, 334 women), 39.2% had osteoporosis. The prevalence of sarcopenia and depression was 18.9% and 42.1%, respectively. Logistic regression analysis showed that SMI was significantly associated with a decreased risk of osteoporosis (OR = 0.638, 95% CI = 0.494-0.823, P = 0.001), while HGS was not(OR = 0.990, 95% CI = 0.963-1.017, P = 0.449). HD patients with sarcopenia were 1.92 times more likely to have osteoporosis than those without sarcopenia. Most notably, after adjusting for both sarcopenia and SMI, the risk of osteoporosis in HD patients with depression was 1.45 times higher than in those without depression (OR = 1.452, 95% CI = 1.060-1.989, P = 0.020).RESULTSAmong the 858 participants (524 men, 334 women), 39.2% had osteoporosis. The prevalence of sarcopenia and depression was 18.9% and 42.1%, respectively. Logistic regression analysis showed that SMI was significantly associated with a decreased risk of osteoporosis (OR = 0.638, 95% CI = 0.494-0.823, P = 0.001), while HGS was not(OR = 0.990, 95% CI = 0.963-1.017, P = 0.449). HD patients with sarcopenia were 1.92 times more likely to have osteoporosis than those without sarcopenia. Most notably, after adjusting for both sarcopenia and SMI, the risk of osteoporosis in HD patients with depression was 1.45 times higher than in those without depression (OR = 1.452, 95% CI = 1.060-1.989, P = 0.020).In HD patients, increased muscle mass, rather than muscle strength, is linked to a lower risk of osteoporosis. Notably, depression emerges as a significant risk factor for osteoporosis in this population, highlighting the need for mental health considerations in managing bone health.CONCLUSIONSIn HD patients, increased muscle mass, rather than muscle strength, is linked to a lower risk of osteoporosis. Notably, depression emerges as a significant risk factor for osteoporosis in this population, highlighting the need for mental health considerations in managing bone health. Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental health issue in this population. Despite the prevalence of these conditions, the interrelationships among them remain poorly understood in HD patients. In this multicenter cross-sectional study, 858 HD patients from 7 dialysis centers were recruited. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry. Skeletal muscle mass index (SMI) was calculated from body composition data obtained through multifrequency bioimpedance analysis (BIA), while handgrip strength (HGS) was measured with a dynamometer. Gait speed was evaluated with a 4-meter walk test, and depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). Among the 858 participants (524 men, 334 women), 39.2% had osteoporosis. The prevalence of sarcopenia and depression was 18.9% and 42.1%, respectively. Logistic regression analysis showed that SMI was significantly associated with a decreased risk of osteoporosis (OR = 0.638, 95% CI = 0.494-0.823, P = 0.001), while HGS was not(OR = 0.990, 95% CI = 0.963-1.017, P = 0.449). HD patients with sarcopenia were 1.92 times more likely to have osteoporosis than those without sarcopenia. Most notably, after adjusting for both sarcopenia and SMI, the risk of osteoporosis in HD patients with depression was 1.45 times higher than in those without depression (OR = 1.452, 95% CI = 1.060-1.989, P = 0.020). In HD patients, increased muscle mass, rather than muscle strength, is linked to a lower risk of osteoporosis. Notably, depression emerges as a significant risk factor for osteoporosis in this population, highlighting the need for mental health considerations in managing bone health. Background Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental health issue in this population. Despite the prevalence of these conditions, the interrelationships among them remain poorly understood in HD patients. Methods In this multicenter cross-sectional study, 858 HD patients from 7 dialysis centers were recruited. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry. Skeletal muscle mass index (SMI) was calculated from body composition data obtained through multifrequency bioimpedance analysis (BIA), while handgrip strength (HGS) was measured with a dynamometer. Gait speed was evaluated with a 4-meter walk test, and depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). Results Among the 858 participants (524 men, 334 women), 39.2% had osteoporosis. The prevalence of sarcopenia and depression was 18.9% and 42.1%, respectively. Logistic regression analysis showed that SMI was significantly associated with a decreased risk of osteoporosis (OR = 0.638, 95% CI = 0.494-0.823, P = 0.001), while HGS was not(OR = 0.990, 95% CI = 0.963-1.017, P = 0.449). HD patients with sarcopenia were 1.92 times more likely to have osteoporosis than those without sarcopenia. Most notably, after adjusting for both sarcopenia and SMI, the risk of osteoporosis in HD patients with depression was 1.45 times higher than in those without depression (OR = 1.452, 95% CI = 1.060-1.989, P = 0.020). Conclusions In HD patients, increased muscle mass, rather than muscle strength, is linked to a lower risk of osteoporosis. Notably, depression emerges as a significant risk factor for osteoporosis in this population, highlighting the need for mental health considerations in managing bone health. Keywords: Sarcopenia, Depression, Osteoporosis, Hemodialysis, Bone mineral density |
ArticleNumber | 35 |
Audience | Academic |
Author | Yu, Chen Chen, Haimin Qi, Hualin Niu, Jianying Wu, Bibo Zhang, Liming Hu, Xiaohua Zhao, Junli Zhang, Suhua Xue, Cheng Ding, Wei Ye, Xianwu Guo, Qi |
Author_xml | – sequence: 1 givenname: Xiaohua surname: Hu fullname: Hu, Xiaohua – sequence: 2 givenname: Xianwu surname: Ye fullname: Ye, Xianwu – sequence: 3 givenname: Haimin surname: Chen fullname: Chen, Haimin – sequence: 4 givenname: Bibo surname: Wu fullname: Wu, Bibo – sequence: 5 givenname: Qi surname: Guo fullname: Guo, Qi – sequence: 6 givenname: Chen surname: Yu fullname: Yu, Chen – sequence: 7 givenname: Wei surname: Ding fullname: Ding, Wei – sequence: 8 givenname: Jianying surname: Niu fullname: Niu, Jianying – sequence: 9 givenname: Junli surname: Zhao fullname: Zhao, Junli – sequence: 10 givenname: Hualin surname: Qi fullname: Qi, Hualin – sequence: 11 givenname: Suhua surname: Zhang fullname: Zhang, Suhua – sequence: 12 givenname: Cheng surname: Xue fullname: Xue, Cheng – sequence: 13 givenname: Liming surname: Zhang fullname: Zhang, Liming |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39849392$$D View this record in MEDLINE/PubMed |
BookMark | eNptkstu1TAQhiNURC_wAiyQJTZsUnyJY4cNqsqtUiU2sLYce3LqQxIHO6nU1-CJmZxTSg9CUW6eb_7JH_-nxdEYRyiKl4yeM6brt5lxrXlJuSypaGpRsifFCasUK7mom6NHz8fFac5bSpnSFX1WHItGV41o-Enx6wNMCXIOcSQ2E0tSyD9IZ90cE-nwjHmGOMUUc8gkjB4mwMs4k9iRbJOL-B4sVsgNDNEH29-t5GTngFR-RzpsCuMmky7FAQcMSz8HhzVIxKFsLjO4GefbnuR58XfPi6ed7TO8uL-fFd8_ffx2-aW8_vr56vLiunSSybkUthK68kIq4VpHfd065bTgdcM1562HxoNopXOcS8mUk02lWds6L4USHQVxVlztdX20WzOlMNh0Z6INZrcQ08bYhJ_ag5G6xhYcB1JVDOda2UJjuaYcfFdXqPV-rzUt7QB-tZdsfyB6WBnDjdnEW8OYklJrgQpv7hVS_LlAns0QsoO-tyPEJRvB0IBAfyv6-h90G5eE_2-lajTbKKr-UhuLDsLYRRzsVlFzoXlVN4rTGqnz_1B4eBiCw7x1AdcPGl49dvpg8U-kEOB7YLe5CboHhFGz5tbsc2swt2aXW8PEb13K4UA |
Cites_doi | 10.1093/ndt/gfaa192 10.1038/s41430-019-0468-z 10.1016/j.clnu.2020.07.025 10.1097/MNH.0000000000000318 10.3389/fendo.2023.1181139 10.1007/s00774-017-0895-7 10.1007/s11255-017-1738-0 10.1016/j.bone.2015.04.016 10.1016/j.heliyon.2023.e19383 10.1016/j.bone.2010.01.382 10.1016/j.jamda.2013.11.025 10.1002/jcsm.12890 10.1016/S1043-2760(01)00407-6 10.1016/j.tem.2009.05.003 10.1016/j.afos.2021.04.001 10.2215/CJN.10261013 10.1186/s42358-020-0118-0 10.1007/s11255-015-0977-1 10.4103/sja.SJA_543_18 10.1046/j.1525-1497.2001.016009606.x 10.3390/nu13010147 10.3389/fmed.2020.00187 10.1001/jama.285.6.785 10.1007/s10157-022-02308-8 10.1007/s40620-020-00840-y 10.1016/j.nut.2019.02.013 |
ContentType | Journal Article |
Copyright | 2025. The Author(s). COPYRIGHT 2025 BioMed Central Ltd. 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2025 2025 |
Copyright_xml | – notice: 2025. The Author(s). – notice: COPYRIGHT 2025 BioMed Central Ltd. – notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2025 2025 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12882-025-03963-1 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Statistics |
EISSN | 1471-2369 |
EndPage | 11 |
ExternalDocumentID | oai_doaj_org_article_5863f0384e5741438a5be9a2802edf64 PMC11755883 A824697206 39849392 10_1186_s12882_025_03963_1 |
Genre | Multicenter Study Journal Article |
GeographicLocations | China Japan |
GeographicLocations_xml | – name: China – name: Japan |
GrantInformation_xml | – fundername: Shanghai Jing'an District Health Commission Research Project grantid: 2022MS04 – fundername: Shanghai science and technology innovation action plan of scientific instruments and chemical reagents project grantid: 24142201800 |
GroupedDBID | --- 0R~ 23N 2WC 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABUWG ACGFO ACGFS ACIHN ACPRK ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB CGR CUY CVF ECM EIF NPM PJZUB PPXIY PMFND 3V. 7QP 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c515t-3a4384d3573cbc0d6bc7c832692822bde9de3b5cc225517c59481bbcd5373f0e3 |
IEDL.DBID | M48 |
ISSN | 1471-2369 |
IngestDate | Wed Aug 27 01:25:57 EDT 2025 Thu Aug 21 18:40:58 EDT 2025 Fri Jul 11 09:31:45 EDT 2025 Fri Jul 25 22:13:33 EDT 2025 Tue Jun 17 21:55:56 EDT 2025 Tue Jun 10 20:55:18 EDT 2025 Fri Aug 01 03:41:37 EDT 2025 Tue Jul 01 02:25:21 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Osteoporosis Sarcopenia Depression Bone mineral density Hemodialysis |
Language | English |
License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c515t-3a4384d3573cbc0d6bc7c832692822bde9de3b5cc225517c59481bbcd5373f0e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://doaj.org/article/5863f0384e5741438a5be9a2802edf64 |
PMID | 39849392 |
PQID | 3165519707 |
PQPubID | 44769 |
PageCount | 11 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_5863f0384e5741438a5be9a2802edf64 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11755883 proquest_miscellaneous_3159438323 proquest_journals_3165519707 gale_infotracmisc_A824697206 gale_infotracacademiconefile_A824697206 pubmed_primary_39849392 crossref_primary_10_1186_s12882_025_03963_1 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-01-23 |
PublicationDateYYYYMMDD | 2025-01-23 |
PublicationDate_xml | – month: 01 year: 2025 text: 2025-01-23 day: 23 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC nephrology |
PublicationTitleAlternate | BMC Nephrol |
PublicationYear | 2025 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | H Lee (3963_CR9) 2020; 29 S Cuschieri (3963_CR19) 2019; 13 R Matsuzawa (3963_CR7) 2021; 40 G Cizza (3963_CR29) 2001; 12 A Sabatino (3963_CR8) 2021; 34 K Ito (3963_CR14) 2020; 7 X Shu (3963_CR27) 2022; 13 N Isoyama (3963_CR5) 2014; 9 P Evenepoel (3963_CR4) 2021; 36 D Prevention (3963_CR2) 2001; 285 T Xiang (3963_CR10) 2023; 14 D Karasik (3963_CR25) 2010; 46 M Ozawa (3963_CR12) 2023; 27 LK Chen (3963_CR20) 2014; 15 L Amiri (3963_CR22) 2017; 55 H Tominaga (3963_CR15) 2018; 27 Y Li (3963_CR16) 2023; 9 K Kroenke (3963_CR21) 2001; 16 SC Chen (3963_CR13) 2019; 65 F Al Zaben (3963_CR28) 2015; 47 M Slouma (3963_CR3) 2020; 60 G Cizza (3963_CR18) 2009; 20 MZC da Silva (3963_CR6) 2019; 73 G Gerogianni (3963_CR17) 2018; 50 T Tachiki (3963_CR11) 2019; 37 3963_CR26 R Abdala (3963_CR30) 2021; 7 3963_CR23 MH Edwards (3963_CR24) 2015; 80 S Tanaka (3963_CR1) 2015; 25 |
References_xml | – volume: 36 start-page: 42 issue: 1 year: 2021 ident: 3963_CR4 publication-title: Nephrol Dial Transpl doi: 10.1093/ndt/gfaa192 – volume: 73 start-page: 1209 issue: 8 year: 2019 ident: 3963_CR6 publication-title: Eur J Clin Nutr doi: 10.1038/s41430-019-0468-z – volume: 40 start-page: 1161 issue: 3 year: 2021 ident: 3963_CR7 publication-title: Clin Nutr doi: 10.1016/j.clnu.2020.07.025 – ident: 3963_CR23 doi: 10.1097/MNH.0000000000000318 – volume: 25 start-page: 1057 issue: 7 year: 2015 ident: 3963_CR1 publication-title: Clin Calcium – volume: 14 start-page: 1181139 year: 2023 ident: 3963_CR10 publication-title: Front Endocrinol doi: 10.3389/fendo.2023.1181139 – volume: 37 start-page: 53 issue: 1 year: 2019 ident: 3963_CR11 publication-title: J Bone Min Metab doi: 10.1007/s00774-017-0895-7 – volume: 50 start-page: 143 issue: 1 year: 2018 ident: 3963_CR17 publication-title: Int Urol Nephrol doi: 10.1007/s11255-017-1738-0 – volume: 55 start-page: 92 issue: 2 year: 2017 ident: 3963_CR22 publication-title: Acta Med Iran – volume: 80 start-page: 126 year: 2015 ident: 3963_CR24 publication-title: Bone doi: 10.1016/j.bone.2015.04.016 – volume: 9 start-page: e19383 issue: 9 year: 2023 ident: 3963_CR16 publication-title: Heliyon doi: 10.1016/j.heliyon.2023.e19383 – volume: 46 start-page: 1226 issue: 5 year: 2010 ident: 3963_CR25 publication-title: Bone doi: 10.1016/j.bone.2010.01.382 – volume: 15 start-page: 95 issue: 2 year: 2014 ident: 3963_CR20 publication-title: J Am Med Dir Assoc doi: 10.1016/j.jamda.2013.11.025 – volume: 29 start-page: 712 issue: 4 year: 2020 ident: 3963_CR9 publication-title: Asia Pac J Clin Nutr – volume: 13 start-page: 145 issue: 1 year: 2022 ident: 3963_CR27 publication-title: J cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12890 – volume: 12 start-page: 198 issue: 5 year: 2001 ident: 3963_CR29 publication-title: Trends Endocrinol Metab doi: 10.1016/S1043-2760(01)00407-6 – volume: 20 start-page: 367 issue: 8 year: 2009 ident: 3963_CR18 publication-title: Trends Endocrinol Metab doi: 10.1016/j.tem.2009.05.003 – volume: 7 start-page: 75 issue: 2 year: 2021 ident: 3963_CR30 publication-title: Osteoporos Sarcopenia doi: 10.1016/j.afos.2021.04.001 – volume: 9 start-page: 1720 issue: 10 year: 2014 ident: 3963_CR5 publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.10261013 – volume: 60 start-page: 15 issue: 1 year: 2020 ident: 3963_CR3 publication-title: Adv Rheumatol doi: 10.1186/s42358-020-0118-0 – volume: 47 start-page: 1001 issue: 6 year: 2015 ident: 3963_CR28 publication-title: Int Urol Nephrol doi: 10.1007/s11255-015-0977-1 – volume: 13 start-page: S31 issue: Suppl 1 year: 2019 ident: 3963_CR19 publication-title: Saudi J Anaesth doi: 10.4103/sja.SJA_543_18 – volume: 16 start-page: 606 issue: 9 year: 2001 ident: 3963_CR21 publication-title: J Gen Intern Med doi: 10.1046/j.1525-1497.2001.016009606.x – ident: 3963_CR26 doi: 10.3390/nu13010147 – volume: 7 start-page: 187 year: 2020 ident: 3963_CR14 publication-title: Front Med (Lausanne) doi: 10.3389/fmed.2020.00187 – volume: 285 start-page: 785 issue: 6 year: 2001 ident: 3963_CR2 publication-title: JAMA doi: 10.1001/jama.285.6.785 – volume: 27 start-page: 365 issue: 4 year: 2023 ident: 3963_CR12 publication-title: Clin Exp Nephrol doi: 10.1007/s10157-022-02308-8 – volume: 34 start-page: 1347 issue: 4 year: 2021 ident: 3963_CR8 publication-title: J Nephrol doi: 10.1007/s40620-020-00840-y – volume: 27 start-page: 1062 issue: 5 year: 2018 ident: 3963_CR15 publication-title: Asia Pac J Clin Nutr – volume: 65 start-page: 6 year: 2019 ident: 3963_CR13 publication-title: Nutrition doi: 10.1016/j.nut.2019.02.013 |
SSID | ssj0017840 |
Score | 2.3617845 |
Snippet | Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental... Background Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common... BackgroundOsteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common... Abstract Background Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 35 |
SubjectTerms | Absorptiometry, Photon Aged Body composition Bone composition Bone Density Bone diseases Bone mass Bone mineral density Cholesterol Chronic illnesses Comorbidity Complications and side effects Cross-Sectional Studies Depression Depression - complications Depression - epidemiology Depression, Mental Diseases Dual energy X-ray absorptiometry End-stage renal disease Exercise Female Females Fractures Gait Hand Strength Hemodialysis Hemodialysis patients Humans Investigations Kidney diseases Kidney Failure, Chronic - complications Kidney Failure, Chronic - epidemiology Kidney Failure, Chronic - psychology Kidney Failure, Chronic - therapy Male Males Malnutrition Mental depression Mental disorders Mental health Middle Aged Mortality Muscle strength Osteoporosis Osteoporosis - epidemiology Population studies Prevalence Psychological aspects Questionnaires Regression analysis Renal Dialysis - trends Risk Factors Sample size Sarcopenia Sarcopenia - epidemiology Skeletal muscle Sociodemographics Statistics |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Jb9UwELZQDxUXxE6gIFdC4oCsJhnbcbiVpaoqlROVerO8hb4DCWpe_0h_MTNO8vQiDly4ZhzFnsUzjme-Yex9rZIyqalEMkYJ6WQpXDRaRDx-dKFKKgb633H5XZ9fyYtrdb3X6otywiZ44IlxJ8po6EowMil0fhKMUz61rjZlnWKnMxIo-rzlMDXfHzR4bllKZIw-GXEXxkiSWreWgConqpUbymj9f-_Je05pnTC554HOHrNHc-jIT6cpP2EPUv-UHV7Ol-PP2P3XJau1527kjlPaOJ8a6nCMTTnVcwwYbw_jZuSbXf_bLR86PqLCUyetjUMKv0m_BqooIbgSPkOvjp94vuDuf46cilLwAzkbkWabbnlepxhzZhdNM-PWPmdXZ99-fDkXc8sFETCw2QpwyGEZQTUQfCij9qEJaPS6pXRTH1MbE3gVAm4DqmpCBnvxPkQFDYopwQt20A99esV4G7oaElIrB1J2pZcthC60KMkmxTIW7OMiAft7Qtaw-URitJ3kZVFeNsvLVgX7TELajSRU7PwAdcXOumL_pSsF-0AitmS7KMfg5hIEnDChYNlTU0vdNnWpC3a0Gok2F9bkRUnsbPOjhUorKgMum4Id78j0JuWx9Wm4ozHIMUCGQsFeTjq1WxIga1oMVwtmVtq2WvOa0m9uMiI44a0qY-D1_-DSG_awzpZSiRqO2MH29i69xchr699lI_sDjH0s2w priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4k2gICMhcUBWk_gZLqg8qgqpnKi0NyuxnXYPJGW9_SP8YmYcJzRC4rrjaMeeh8f2zDeEvK1lkCboigVjJBOtKFnrjWIejh-9q4L0Du87zr6r03PxbSM3-cIt5rTK2ScmR-1Hh3fkR7xSEossS_3x6hfDrlH4uppbaNwmdxC6DFO69GY5cFUaTi9zoYxRRxF8McST2MC15KB4rFptRgmz_1_PfGNrWqdN3tiHTh6Q-zmApMeTxB-SW2F4RO6e5Sfyx-T3lzm3daBtpC3F5HE6tdWhEKFSrOoYIeoe4zbS7dIFd0_HnkZQe-yntW2BQi_DzxHrShC0hGYA1viBpmfu4SJSLE2BP0g5icht2NE0TxZTfheymdBrn5Dzk68_Pp-y3HiBOQhv9oy3ghvhudTcda70qnPagemrBpNOOx8aH3gnnQNnICvtEuRL1zkvueZ9GfhTcjCMQ3hOaOP6mgegVi0Xoi870XDXu8aIoIMvfUHezxKwVxO-hk3nEqPsJC8L8rJJXrYqyCcU0jISsbHTD-PuwmZTs9IoYAImECSESzCTVnahaWtT1sH3ShTkHYrYogWDHF2bCxGAYcTCssemFqrRdakKcrgaCZbn1uRZSWy2_Gj_6mlB3ixk_BKz2YYwXuMYWDEOC8oL8mzSqWVKHJamgaC1IGalbas5rynD9jLhgiPqqjSGv_g_Xy_JvTrZQMVqfkgO9rvr8Aoiq333OpnPH6whJVY priority: 102 providerName: ProQuest |
Title | Depression as a risk factor for osteoporosis independent of sarcopenia in hemodialysis patients: findings from a multicenter cross-sectional study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39849392 https://www.proquest.com/docview/3165519707 https://www.proquest.com/docview/3159438323 https://pubmed.ncbi.nlm.nih.gov/PMC11755883 https://doaj.org/article/5863f0384e5741438a5be9a2802edf64 |
Volume | 26 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9RAEF9qC-KL-N3Ueqwg-CDRJPsZQeSqLeXgiqgH97Yku5v2QBN7uYL-G_7FzmySs8E--HRws3fZ-dqdzc78hpAXmfBCe5XGXmsR84InceG0jB0cPyqbeuEsvu-Yn8nTBZ8txXKHDO2OegG2Nx7tsJ_UYv3t9c_LX-_B4d8Fh9fyTQtrLMSJ2Jg1YWBQMZyG9mBnUuioc_73VkHprkASFuQ4YzIfimhu_I_RRhXw_P9dta9tW-OUymt71Mk9crcPLum0s4b7ZMfXD8jteX99_pD8_jjkvda0aGlBMbGcdi13KESvFCs-GhBG065autp2yN3QpqItuATKZlUAhV747w3WnCCgCe3BWdu3NFyB1-ctxbIVeEDIV8TZ-jUNfMZtyP3CaQZk20dkcXL89cNp3DdliC2EPpuYFZxp7phQzJY2cbK0ysKyIHNMSC2dz51npbAWFgqRKhvgYMrSOsEUqxLPHpPduqn9PqG5rTLmgZoWjPMqKXnObGVzzb3yLnEReTVowPzosDdMOLNoaTp9GdCXCfoyaUSOUEnbkYibHb5o1uemd0MjtIRJAANeQCgFnBSi9HmR6STzrpI8Ii9RxQbtDfRoi75IASaMOFlmqjMuc5UlMiKHo5HglXZMHozEDEZtWCoFFgonKiLPt2T8JWa61b65wjEgMQYCZRF50tnUliUGoskhoI2IHlnbiOcxpV5dBMxwRGQVWrOD_3jwU3InC46AXnJIdjfrK_8MQq9NOSG31FJNyN50Ovsyg8-j47NPnyfhRcYk-Nof7qMxZw |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFS2EnBBvAkUMBKIA4qaxHbiICHU0lZb2l0h1Eq9uYnttHsgKZutEL_Bh_CNzHiTpRESt14z3o3H847nAfA6kU4ql8WhU0qGohBRWFiVhhbDj8rETlpD3zsm03R8LD6fyJM1-N3XwlBaZa8TvaK2jaFv5Js8TiUVWUbZx4vvIU2NotvVfoTGki0O3M8fGLK1H_Z3kL5vkmRv9-jTOOymCoQGbfci5IXgSlguM25KE9m0NJlBvk5zyqgsrcut46U0Bjldxpnx_UzK0ljJM15FjuP_3oB1wTGUGcH69u70y9fVvUWG8VJfmqPSzRa1P3qwNDI24sjqYTwwf35KwL-24IoxHCZqXrF8e3fhTueysq0lj92DNVffh5uT7lL-Afza6bNpa1a0rGCUrs6Wg3wY-sSM6kga9PObdtay2Wru7oI1FWvxRGmC16xACDt33xqqZKE2Kaxr-dq-Z_5ivT5rGRXD4At8FiTt1s2ZxzNsfUYZbdP3y30Ix9dClEcwqpvaPQGWmyrhDqFxwYWoolLk3FQmV8JlzkY2gHc9BfTFsqOH9pGQSvWSXhrppT29dBzANhFptZK6cfsHzfxMd8KtpUpxE4iAk-igISaFLF1eJCpKnK1SEcBbIrEmnYF0NEVX-oAbpu5bekslIs2zJEoD2BisRFk3Q3DPJLrTNa3-KxkBvFqB6ZeUP1e75pLW4IlxPFAewOMlT61Q4ng0ObrJAagBtw1wHkLq2bnvRE59XqVS_On_9_USbo2PJof6cH968AxuJ14e4jDhGzBazC_dc_TrFuWLTpgYnF63_P4B9YZjUQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Depression+as+a+risk+factor+for+osteoporosis+independent+of+sarcopenia+in+hemodialysis+patients%3A+findings+from+a+multicenter+cross-sectional+study&rft.jtitle=BMC+nephrology&rft.au=Hu%2C+Xiaohua&rft.au=Ye%2C+Xianwu&rft.au=Chen%2C+Haimin&rft.au=Wu%2C+Bibo&rft.date=2025-01-23&rft.issn=1471-2369&rft.eissn=1471-2369&rft.volume=26&rft.issue=1&rft.spage=35&rft_id=info:doi/10.1186%2Fs12882-025-03963-1&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2369&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2369&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2369&client=summon |